Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 1998. Start Trial.
Date Value
October 23, 2026 44.10B
October 22, 2026 44.56B
October 21, 2026 42.66B
October 20, 2026 42.98B
October 19, 2026 41.56B
October 16, 2026 41.43B
October 15, 2026 41.83B
October 14, 2026 41.46B
October 13, 2026 40.88B
October 12, 2026 40.95B
October 09, 2026 40.41B
October 08, 2026 39.33B
October 07, 2026 39.88B
October 06, 2026 39.99B
October 05, 2026 40.09B
October 02, 2026 39.55B
October 01, 2026 39.98B
September 30, 2026 40.43B
September 29, 2026 40.61B
September 28, 2026 40.85B
September 25, 2026 40.69B
September 24, 2026 40.50B
September 23, 2026 40.68B
September 22, 2026 40.36B
September 21, 2026 39.43B
Date Value
September 18, 2026 38.90B
September 17, 2026 39.42B
September 16, 2026 38.97B
September 15, 2026 39.00B
September 14, 2026 39.17B
September 11, 2026 39.14B
September 10, 2026 38.89B
September 09, 2026 38.19B
September 08, 2026 38.46B
September 04, 2026 39.69B
September 03, 2026 40.23B
September 02, 2026 39.96B
September 01, 2026 38.98B
August 31, 2026 39.07B
August 28, 2026 39.34B
August 27, 2026 39.79B
August 26, 2026 39.72B
August 25, 2026 39.68B
August 24, 2026 39.29B
August 21, 2026 39.09B
August 20, 2026 38.73B
August 19, 2026 39.79B
August 18, 2026 38.46B
August 17, 2026 37.96B
August 14, 2026 38.06B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
AbbVie, Inc. 569.05B
Gilead Sciences, Inc. 214.93B
Amgen, Inc. 280.78B
Ionis Pharmaceuticals, Inc. 7.245B
Regeneron Pharmaceuticals, Inc. 77.94B